1. Home
  2. VALN vs GDOT Comparison

VALN vs GDOT Comparison

Compare VALN & GDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VALN
  • GDOT
  • Stock Information
  • Founded
  • VALN 2012
  • GDOT 1999
  • Country
  • VALN France
  • GDOT United States
  • Employees
  • VALN N/A
  • GDOT N/A
  • Industry
  • VALN Biotechnology: Biological Products (No Diagnostic Substances)
  • GDOT Finance: Consumer Services
  • Sector
  • VALN Health Care
  • GDOT Finance
  • Exchange
  • VALN Nasdaq
  • GDOT Nasdaq
  • Market Cap
  • VALN 669.2M
  • GDOT 610.4M
  • IPO Year
  • VALN 2021
  • GDOT 2010
  • Fundamental
  • Price
  • VALN $9.11
  • GDOT $9.65
  • Analyst Decision
  • VALN Strong Buy
  • GDOT Hold
  • Analyst Count
  • VALN 3
  • GDOT 3
  • Target Price
  • VALN $15.33
  • GDOT $11.00
  • AVG Volume (30 Days)
  • VALN 65.5K
  • GDOT 674.6K
  • Earning Date
  • VALN 08-12-2025
  • GDOT 08-11-2025
  • Dividend Yield
  • VALN N/A
  • GDOT N/A
  • EPS Growth
  • VALN N/A
  • GDOT N/A
  • EPS
  • VALN N/A
  • GDOT N/A
  • Revenue
  • VALN $201,099,222.00
  • GDOT $1,825,327,000.00
  • Revenue This Year
  • VALN $18.61
  • GDOT $22.44
  • Revenue Next Year
  • VALN $25.07
  • GDOT $12.64
  • P/E Ratio
  • VALN N/A
  • GDOT N/A
  • Revenue Growth
  • VALN 21.64
  • GDOT 18.98
  • 52 Week Low
  • VALN $3.62
  • GDOT $6.13
  • 52 Week High
  • VALN $9.10
  • GDOT $13.58
  • Technical
  • Relative Strength Index (RSI)
  • VALN 80.93
  • GDOT 36.21
  • Support Level
  • VALN $7.15
  • GDOT $9.69
  • Resistance Level
  • VALN $7.82
  • GDOT $10.06
  • Average True Range (ATR)
  • VALN 0.40
  • GDOT 0.36
  • MACD
  • VALN 0.14
  • GDOT -0.10
  • Stochastic Oscillator
  • VALN 99.37
  • GDOT 19.88

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About GDOT Green Dot Corporation $0.001 par value

Green Dot Corp is a financial technology company that provides financial services for consumers in the United States without good banking options. It has three segments Consumer Services, Business to Business Services(B2B), and Money Movement Services. The company generates maximum revenue from B2B segment. Its B2B Services segment consists of revenues and expenses derived from (i) its partnerships with prominent consumer and technology companies that make banking products and services available to their consumers, partners and workforce through integration with its banking platform (the "Banking-as-a-Service", or "BaaS channel"), and (ii) a comprehensive payroll platform that it offers to corporate enterprises (the "Employer channel") to facilitate payments for today's workforce.

Share on Social Networks: